Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marthe Minderman"'
Autor:
Marthe Minderman, Hildo Lantermans, Carmen van der Zwaan, Arie J. Hoogendijk, Maartje van den Biggelaar, Marie José Kersten, Marcel Spaargaren, Steven T. Pals
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract MYD88 is the key signaling adaptor-protein for Toll-like and interleukin-1 receptors. A somatic L265P mutation within the Toll/interleukin-1 receptor (TIR) domain of MYD88 is found in 90% of Waldenström macroglobulinemia cases and in a sign
Externí odkaz:
https://doaj.org/article/6567367aa7a8454c9dcdd166992c7d1a
Autor:
Marthe Minderman, Hildo C. Lantermans, Leonie J. Grüneberg, Saskia A. G. M. Cillessen, Richard J. Bende, Carel J. M. van Noesel, Marie José Kersten, Steven T. Pals, Marcel Spaargaren
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract The paracaspase mucosa-associated lymphoid tissue 1 (MALT1) is a protease and scaffold protein essential in propagating B-cell receptor (BCR) signaling to NF-κB. The deubiquitinating enzyme cylindromatosis (CYLD) is a recently discovered MA
Externí odkaz:
https://doaj.org/article/fa21a09a30c54eef9cb4825a4c293ec2
Autor:
Marthe Minderman, Steven T. Pals
Publikováno v:
Haematologica, Vol 105, Iss 9 (2020)
Externí odkaz:
https://doaj.org/article/2286aa5af9c648d0b7097439141a1ae0
Autor:
Martijn H. den Brok, Christian Büll, Melissa Wassink, Annemarie M. de Graaf, Jori A. Wagenaars, Marthe Minderman, Mayank Thakur, Sebastian Amigorena, Eric O. Rijke, Carla C. Schrier, Gosse J. Adema
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Saponin-based adjuvants are being explored as vaccine components as they induce high levels of antigen cross-presentation, but it is unknown how. Here the authors show that these adjuvants enhance cross-presentation by driving production of lipid bod
Externí odkaz:
https://doaj.org/article/5b83830e5f2e45ffac906cc79476ab4a
Autor:
Steffen Heegaard, Lene Dissing Sjö, Marthe Minderman, Marina Knudsen Kirkegaard, Patrick Rene Gerhard Eriksen, Steven T. Pals
Publikováno v:
British Journal of Ophthalmology. 107:576-581
AimsTo (1) reclassify ocular adnexal large B-cell lymphomas (OA-LBCLs) per 2016 WHO lymphoma classification and (2) determine the prevalence ofMYD88andCD79Bmutations and their association with clinical parameters among OA-LBCLs.MethodsThis study is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcbd4ad14580b50fda354606f92bc03d
https://doi.org/10.1136/bjophthalmol-2021-319580
https://doi.org/10.1136/bjophthalmol-2021-319580
Autor:
Marina Knudsen, Kirkegaard, Marthe, Minderman, Lene Dissing, Sjö, Steven T, Pals, Patrick R G, Eriksen, Steffen, Heegaard
Publikováno v:
The British journal of ophthalmology.
To (1) reclassify ocular adnexal large B-cell lymphomas (OA-LBCLs) per 2016 WHO lymphoma classification and (2) determine the prevalence ofThis study is a retrospective analysis of all OA-LBCLs diagnosed in Denmark between 1980 and 2018. Medical reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1cc9baa603573386018bfce1177c1b37
https://pubmed.ncbi.nlm.nih.gov/34706861
https://pubmed.ncbi.nlm.nih.gov/34706861
Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
Autor:
Marcel Spaargaren, Marie-Jose Kersten, Steven T. Pals, Annemieke Kuil, Marthe Minderman, Hildo Lantermans
Publikováno v:
Leukemia, 35(3), 881-886. Nature Publishing Group
Leukemia
Leukemia
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin lymphoma subtype arising from naïve B cells. Although novel therapeutics have improved patient prognosis, drug resistance remains a key problem. Here, we show that the SRC-family tyrosine kinas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163300a23c724882fadb79a45e1aca05
https://pure.amc.nl/en/publications/identification-of-the-srcfamily-tyrosine-kinase-hck-as-a-therapeutic-target-in-mantle-cell-lymphoma(6af32ea0-c095-453f-8d1e-564def777779).html
https://pure.amc.nl/en/publications/identification-of-the-srcfamily-tyrosine-kinase-hck-as-a-therapeutic-target-in-mantle-cell-lymphoma(6af32ea0-c095-453f-8d1e-564def777779).html
Autor:
Steven T. Pals, Marthe Minderman
Publikováno v:
Haematologica. 105(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b6deaed8c7774b4949beed013a90a8
https://pubmed.ncbi.nlm.nih.gov/33054054
https://pubmed.ncbi.nlm.nih.gov/33054054
Autor:
Gosse J. Adema, Annemarie M.A. de Graaf, Marthe Minderman, Eric Onno Rijke, Mayank Thakur, Jori A. L. Wagenaars, Christian Büll, Melissa Wassink, Martijn H. den Brok, Schrier Carla Christina, Sebastian Amigorena
Publikováno v:
Nature Communications, 7, 13324-13324
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Nature Communications, 7, pp. 13324-13324
Nature Communications
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Nature Communications, 7, pp. 13324-13324
Nature Communications
Saponin-based adjuvants (SBAs) are being used in animal and human (cancer) vaccines, as they induce protective cellular immunity. Their adjuvant potency is a factor of inflammasome activation and enhanced antigen cross-presentation by dendritic cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed1273b02934123b3e96e31de75248c
http://hdl.handle.net/2066/171462
http://hdl.handle.net/2066/171462